On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
We received an updated WNV package insert; please note the manufacturer and license number has been ...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...